Cargando…

A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is a diffuse, acute, inflammatory lung disease characterized by a severe respiratory failure. Recognizing and promptly treating ARDS is critical to combat the high mortality associated with the disease. Despite a significant progress in the treatment of ARD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parzibut, Gilles, Henket, Monique, Moermans, Catherine, Struman, Ingrid, Louis, Edouard, Malaise, Michel, Louis, Renaud, Misset, Benoît, Njock, Makon-Sébastien, Guiot, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319727/ https://www.ncbi.nlm.nih.gov/pubmed/34336922 http://dx.doi.org/10.3389/fmolb.2021.640042

Ejemplares similares

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
por: Guiot, Julien, et al.
Publicado: (2019)

Exosomal Long Non-Coding RNAs in Lung Diseases
por: Poulet, Christophe, et al.
Publicado: (2020)

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
por: Guiot, Julien, et al.
Publicado: (2023)

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
por: Guiot, Julien, et al.
Publicado: (2020)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

A new nucleosomic-based model to identify and diagnose SSc-ILD
por: Guiot, Julien, et al.
Publicado: (2020)

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
por: Guiot, Julien, et al.
Publicado: (2021)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023)

Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
por: Jacquerie, P., et al.
Publicado: (2021)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
por: Guiot, J., et al.
Publicado: (2017)

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD
por: Corhay, Jean Louis, et al.
Publicado: (2014)

Endothelial extracellular vesicles promote tumour growth by tumour‐associated macrophage reprogramming
por: Njock, Makon‐Sébastien, et al.
Publicado: (2022)

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)

Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
por: O’Grady, Tina, et al.
Publicado: (2022)

Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype
por: Calmes, Doriane, et al.
Publicado: (2021)

Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity
por: Guiot, Julien, et al.
Publicado: (2022)

The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies
por: Fastrès, Aline, et al.
Publicado: (2017)

AI-Based Chest CT Analysis for Rapid COVID-19 Diagnosis and Prognosis: A Practical Tool to Flag High-Risk Patients and Lower Healthcare Costs
por: Esposito, Giovanni, et al.
Publicado: (2022)

Check and mate to exosomal extracellular miRNA: new lesson from a new approach
por: Turchinovich, Andrey, et al.
Publicado: (2015)

Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma?
por: Graff, Sophie, et al.
Publicado: (2021)

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection
por: Calmes, Doriane, et al.
Publicado: (2021)

Reproducibility of pulmonary function tests in patients with systemic sclerosis
por: Jacquerie, P., et al.
Publicado: (2023)

Could KL-6 levels in COVID-19 help to predict lung disease?
por: Frix, AN, et al.
Publicado: (2020)

Exploring the RNA landscape of endothelial exosomes
por: Pérez-Boza, Jennifer, et al.
Publicado: (2018)

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
por: Schleich, Florence, et al.
Publicado: (2023)

Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics
por: Louis, Gilles, et al.
Publicado: (2023)

Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes
por: Han, Siqi, et al.
Publicado: (2021)

The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave
por: Canivet, Perrine, et al.
Publicado: (2022)

Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
por: Cheng, Henry S., et al.
Publicado: (2014)

Predictors of asthma‐related quality of life in a large cohort of asthmatics: A cross‐sectional study in a secondary care center
por: Louis, Gilles, et al.
Publicado: (2021)

Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis
por: Louis, Gilles, et al.
Publicado: (2023)

YKL-40 as a new promising prognostic marker of severity in COVID infection
por: Schoneveld, Lauranne, et al.
Publicado: (2021)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

Revisiting differences between atopic and non-atopic asthmatics: When age is shaping airway inflammatory profile
por: Gerday, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kj6ouinh3pgq5nb1t5bqg8ahpb